Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure.

Some specific features of the 24-hour blood pressure (BP) pattern are linked to the progressive injury of target tissues and the triggering of cardiac and cerebrovascular events. Thus, there is growing interest in how to best tailor the treatment of hypertensive patients according to the circadian BP pattern of each individual. Significant administration-time differences in the kinetics (i.e., chronokinetics) plus beneficial and adverse effects (i.e., chronodynamics) of antihypertensive medications are well known. Thus, bedtime dosing with nifedipine GITS is more effective than morning dosing, while also significantly reducing adverse effects. The dose-response curve, therapeutic coverage, and efficacy of doxazosin GITS are all markedly dependent on the circadian time of drug administration. Moreover, valsartan administration at bedtime, as opposed to upon wakening, results in an improved diurnal/nocturnal BP ratio, increased percentage of controlled patients, and significant reduction in urinary albumin excretion in hypertensive patients. Chronotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease (myocardial infarction and stroke) and of end-organ injury of the blood vessels and tissue of the heart, brain, kidney, eye, and other organs.

[1]  R. Hermida,et al.  Treatment of non-dipper hypertension with bedtime administration of valsartan , 2005, Journal of hypertension.

[2]  M. Sasaki,et al.  Timing for Administration of an Antihypertensive Drug in the Treatment of Essential Hypertension , 1994, Hypertension.

[3]  K. Kario,et al.  Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[4]  J. Devane,et al.  A Steady-State Evaluation of the Bioavailability of Chronotherapeutic Oral Drug Absorption System Verapamil PM After Nighttime Dosing Versus Immediate-Acting Verapamil Dosed Every Eight Hours , 2000, American Journal of Therapeutics.

[5]  W. White,et al.  Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics , 2000, Contemporary Cardiology.

[6]  M. Roncaglioni.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice , 2001, The Lancet.

[7]  E. O’Brien,et al.  DIPPERS AND NON-DIPPERS , 1988, The Lancet.

[8]  Dawn K. Wilson,et al.  Sodium, Potassium, the Sympathetic Nervous System, and the Renin-Angiotensin System: Impact on the Circadian Variability in Blood Pressure , 2000 .

[9]  B. Lemmer,et al.  Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[10]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[11]  M. Smolensky.  Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Findings of two 1996 Gallup surveys. , 1998, Chronobiology international.

[12]  K. Eagle,et al.  Chronobiological Patterns of Acute Aortic Dissection , 2002, Circulation.

[13]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[14]  M. Aboy,et al.  The population RDH index: a novel vector index and graphical method for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity , 2006, Blood pressure monitoring.

[15]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[16]  F. Portaluppi,et al.  From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events. , 1999, Chronobiology international.

[17]  R. Hermida,et al.  P-149: Administration time-dependent effects of amlodipine on ambulatory blood pressure in patients with essential hypertension , 2005 .

[18]  R. Hermida,et al.  Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure , 2005, Current opinion in nephrology and hypertension.

[19]  W. White,et al.  Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. , 2004, American heart journal.

[20]  M. Kikuya,et al.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study , 2002, Journal of hypertension.

[21]  F. Magrini,et al.  High prevalence of cardiac and extracardiac target organ damage in refractory hypertension , 2001, Journal of hypertension.

[22]  N. Cutler,et al.  Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. , 1995, The American journal of cardiology.

[23]  M. Kikuya,et al.  INSUFFICIENT DURATION OF ACTION OF ANTIHYPERTENSIVE DRUGS MEDIATES HIGH BLOOD PRESSURE IN THE MORNINGIN HYPERTENSIVE POPULATION:THE OHASAMA STUDY , 2002, Clinical and experimental hypertension.

[24]  R. C. Hermida,et al.  Efectos de la administración temporalizada de fármacos antihipertensivos en pacientes con hipertensión arterial resistente , 2006 .

[25]  B. Bruguerolle,et al.  Rhythms in Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion , 1997 .

[26]  R. Hermida,et al.  Administration-Time-Dependent Effects of Doxazosin GITS on Ambulatory Blood Pressure of Hypertensive Subjects , 2004, Chronobiology international.

[27]  B. Lemmer,et al.  Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration , 1993, Clinical pharmacology and therapeutics.

[28]  T. Meade,et al.  Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk , 1998, The Lancet.

[29]  P. Pool.  Anomalies in the dosing of diltiazem , 2000, Clinical cardiology.

[30]  M. Tinetti.  Clinical practice. Preventing falls in elderly persons. , 2003, The New England journal of medicine.

[31]  E. Jones,et al.  The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night , 1997, Journal of hypertension.

[32]  A. Fleming,et al.  Penicillin and streptomycin. , 1947, Lancet.

[33]  F. Portaluppi,et al.  Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. , 1995, American journal of hypertension.

[34]  Carlos Calvo,et al.  Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. , 2005, Hypertension.

[35]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[36]  M. Martín-Baranera,et al.  Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect. , 1998, Blood pressure monitoring.

[37]  R. Hermida,et al.  Administration Time‐Dependent Effects of Valsartan on Ambulatory Blood Pressure in Elderly Hypertensive Subjects , 2005, Chronobiology international.

[38]  D. Waters,et al.  Circadian variation in variant angina. , 1984, The American journal of cardiology.

[39]  U. de Faire,et al.  Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy , 2001, Hypertension.

[40]  H. Black,et al.  Chrono: A Community-Based Hypertension Trial of a Chronotherapeutic Formulation of Verapamil , 2002, American journal of therapeutics.

[41]  S. Willich,et al.  Circadian variation in the frequency of sudden cardiac death. , 1987, Circulation.

[42]  R. Hermida,et al.  Administration Time–Dependent Effects of Valsartan on Ambulatory Blood Pressure in Hypertensive Subjects , 2003, Hypertension.

[43]  Chasen,et al.  Cardiovascular triggers and morning events. , 1998, Blood pressure monitoring.

[44]  F. Portaluppi,et al.  Chronopharmacology of Cardiovascular Diseases , 1997 .

[45]  F. Veglio,et al.  AMBULATORY BLOOD PRESSURE MONITORING AND CLINICAL CHARACTERISTICS OF THE TRUE AND WHITE-COAT RESISTANT HYPERTENSION , 2001, Clinical and experimental hypertension.

[46]  B. Lemmer,et al.  Physiology and Pharmacology of Biological Rhythms , 1997, Handbook of Experimental Pharmacology.

[47]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[48]  S. Hayreh,et al.  Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. , 1994, American journal of ophthalmology.

[49]  Julio A. Panza,et al.  Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity , 1991 .

[50]  M. Aboy,et al.  Methodological considerations in the evaluation of the duration of action of antihypertensive therapy using ambulatory blood pressure monitoring. , 2005, Blood pressure monitoring.

[51]  S. Glasser,et al.  Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. , 2003, American journal of hypertension.

[52]  W. Elliott,et al.  Circadian variation in the timing of stroke onset: a meta-analysis. , 1998, Stroke.

[53]  A. Fujimura,et al.  Dosing Time-Dependent Effect of Temocapril on the Mortality of Stroke-Prone Spontaneously Hypertensive Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[54]  M. Smolensky,et al.  Circadian Rhythm and Environmental Determinants of Blood Pressure Regulation in Normal and Hypertensive Conditions , 2001 .

[55]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[56]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[57]  P. D. de Leeuw,et al.  Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. , 2009, Acta medica Scandinavica.

[58]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[59]  M. Middeke,et al.  Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing. , 1991, Chronobiology international.

[60]  G. Parati,et al.  The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension , 1998, Journal of hypertension.

[61]  P. Cugini.  [The treatability of refractory or resistant hypertension by personalized antihypertensive chronotherapy based on ambulatory monitoring of the arterial pressure]. , 1996, Recenti progressi in medicina.

[62]  Mylan C. Cohen,et al.  Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. , 1997, The American journal of cardiology.

[63]  O. Eradiri,et al.  Pharmacokinetics of a Novel Diltiazem HCl Extended‐Release Tablet Formulation for Evening Administration , 2003, Journal of clinical pharmacology.

[64]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[65]  Jun-zhu Chen,et al.  Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate , 2003, Cardiovascular Drugs and Therapy.

[66]  M. Weber,et al.  A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. , 2001, American journal of hypertension.

[67]  Yutaka Imai,et al.  Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study , 2005, Hypertension.

[68]  M. Mcmurdo,et al.  Risk factors and risk assessment tools for falls in hospital in-patients: a systematic review. , 2004, Age and ageing.

[69]  Nold,et al.  Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. , 1998, Blood pressure monitoring.

[70]  M. Smolensky,et al.  Chronotherapy of hypertension , 2004, Current opinion in nephrology and hypertension.

[71]  M. Timio,et al.  Circadian blood pressure changes in patients with chronic renal insufficiency: a prospective study. , 1993, Renal failure.

[72]  P. Palatini.  Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? , 1992, American heart journal.

[73]  J. Mcnames,et al.  The individual RDH index: a novel vector index for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity , 2006, Blood pressure monitoring.

[74]  E. Haus,et al.  Circadian rhythms and clinical medicine with applications to hypertension. , 2001, American journal of hypertension.

[75]  W. Frishman,et al.  Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation. , 2003, Heart disease.

[76]  K. Kario,et al.  Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[77]  J. Neutel,et al.  Comparison of a Chronotherapeutically Administered β Blocker vs. a Traditionally Administered β Blocker in Patients With Hypertension , 2005 .

[78]  M. Smolensky,et al.  Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. , 1996, American journal of hypertension.

[79]  W. White,et al.  Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. , 1999, American journal of hypertension.

[80]  F. Portaluppi,et al.  Chronobiological patterns of onset of acute cerebrovascular diseases. , 1997, Thrombosis research.

[81]  P. Palatini,et al.  Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[82]  P. Palatini,et al.  Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril , 1992, Clinical pharmacology and therapeutics.

[83]  R. Hermida,et al.  Effects of Time of Day of Treatment on Ambulatory Blood Pressure Pattern of Patients With Resistant Hypertension , 2005, Hypertension.

[84]  H. Black,et al.  Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group. , 1997, The American journal of cardiology.

[85]  Carlos Calvo,et al.  Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis , 2002, Chronobiology international.

[86]  D. Myburgh,et al.  24-hour blood pressure control with ramipril : comparison of once-daily morning and evening administration , 1995 .

[87]  R. Hermida,et al.  Administration Time–Dependent Effects of Aspirin on Blood Pressure in Untreated Hypertensive Patients , 2003, Hypertension.

[88]  E. Granieri,et al.  Circadian variability in hemorrhagic stroke. , 2002, JAMA.

[89]  K. Kanmatsuse,et al.  Effect of Morning and Bedtime Dosing with Cilnidipine on Blood Pressure, Heart Rate, and Sympathetic Nervous Activity in Essential Hypertensive Patients , 2004, Journal of cardiovascular pharmacology.

[90]  R. Hermida,et al.  Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. , 2005, Journal of the American College of Cardiology.

[91]  E. Muxfeldt,et al.  Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension , 2003, Blood pressure monitoring.

[92]  R. Hermida,et al.  Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients. , 2002 .

[93]  P. Baumgart,et al.  Circadian rhythm of blood pressure: internal and external time triggers. , 1991, Chronobiology international.

[94]  R. Hermida,et al.  Seasonal Variation of Fibrinogen in Dipper and Nondipper Hypertensive Patients , 2003, Circulation.

[95]  M. Levenstein,et al.  Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group. , 1994, American journal of hypertension.

[96]  K. Kario,et al.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. , 1996, Hypertension.

[97]  G. Remuzzi,et al.  Progression, remission, regression of chronic renal diseases , 2001, The Lancet.

[98]  R. Bigazzi,et al.  Diurnal variations of blood pressure and microalbuminuria in essential hypertension. , 1994, American journal of hypertension.

[99]  K. Tamura,et al.  EFFECT OF IMIDAPRIL IN DIPPER AND NONDIPPER HYPERTENSIVE PATIENTS: COMPARISON BETWEEN MORNING AND EVENING ADMINISTRATION , 2000, Chronobiology international.

[100]  R. Hermida,et al.  Decrease in Urinary Albumin Excretion Associated With the Normalization of Nocturnal Blood Pressure in Hypertensive Subjects , 2005, Hypertension.

[101]  P. Gosse,et al.  [Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours]. , 1992, Therapie.

[102]  B. Lemmer,et al.  Chronopharmacokinetics and cardiovascular effects of nifedipine. , 1991, Chronobiology international.

[103]  H. Black,et al.  Noctural dosing of a novel delivery system of verapamil for systemic hypertension. , 1995, The American journal of cardiology.

[104]  S. Oparil,et al.  Hypertension: A Companion to Brenner and Rector's The Kidney , 2005 .

[105]  B. Lemmer.  Cardiovascular Chronobiology and Chronopharmacology , 2001 .

[106]  R. Hermida,et al.  P-155: Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension , 2005 .

[107]  J. Longstreth,et al.  The Effect of Food, Time of Dosing, and Body Position on the Pharmacokinetics and Pharmacodynamics of Verapamil and Norverapamil , 1995, Journal of clinical pharmacology.

[108]  P. Stone,et al.  Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. , 1999, The American journal of cardiology.

[109]  P. Suter,et al.  Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension , 1994, The clinical investigator.

[110]  R. Fogari,et al.  Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. , 1993, British journal of clinical pharmacology.

[111]  E. Haus,et al.  Biologic Rhythms in Clinical and Laboratory Medicine , 1992, Springer Berlin Heidelberg.

[112]  P. Deedwania,et al.  Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. , 1990, Circulation.

[113]  Francesco Portaluppi,et al.  Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. , 2003, Circulation.

[114]  H. Iwasaki,et al.  Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients. , 1997, Chronobiology international.

[115]  H. Black,et al.  Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. , 1998, American Journal of Cardiology.